Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. announced that it will receive CNY 50,000,000 in an equity round of funding on August 25, 2023. The transaction will include participation from returning investor Jianzhijia Pharmaceutical Chain Group Co., Ltd. The transaction has been approved the 24th meeting of the fifth board of directors of Jianzhijia Pharmaceutical Chain Group Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.5 CNY | -1.25% | +1.74% | -13.30% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.30% | 931M | |
-30.37% | 15.82B | |
-22.51% | 12.65B | |
-22.88% | 6.6B | |
+11.76% | 6.3B | |
-6.01% | 6.11B | |
+64.02% | 4.75B | |
-1.17% | 4.69B | |
-5.58% | 4.02B | |
-7.87% | 3.59B |
- Stock Market
- Equities
- 605266 Stock
- News Jianzhijia Pharmaceutical Chain Group Co., Ltd.
- Yunnan Jianzhijia Chongqing Qinkang Pharmaceutical Co., Ltd. announced that it expects to receive CNY 50 million in funding from Jianzhijia Pharmaceutical Chain Group Co., Ltd.